DAVITA INC. DVA

Latest FY: 2025 Healthcare Medical Care Facilities
Market Price $180.19
Market Cap $11.50B
P/E Ratio 18.31
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑6.5% YoY
$13.64B
3-Yr CAGR: 5.5%
Net Income ↓-20.2% YoY
$746.80M
Net Margin: 5.5%
Free Cash Flow ↓-10.6% YoY
$1.31B
FCF Yield: 11.39%
EPS (Diluted) ↓-8.3% YoY
$9.84
Basic: $10.06
Return on Equity Efficiency
N/A
ROA: 477.8%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (DVA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $10,707.5M $10,313.2M $879.9M $4.29 $1,963.4M $1,134.3M
FY 2017 $10,876.6M +1.6% $10,470.3M $663.6M -24.6% $3.47 -19.1% $1,907.4M $1,002.2M -11.6%
FY 2018 $10,710.0M -1.5% $10,248.1M $159.4M -76.0% $0.92 -73.5% $1,771.6M $784.5M -21.7%
FY 2019 $10,918.4M +1.9% $10,498.8M $811.0M +408.8% $5.27 +472.8% $2,072.4M $1,305.8M +66.5%
FY 2020 $11,039.7M +1.1% $10,756.8M $773.6M -4.6% $6.31 +19.7% $1,979.0M $1,304.5M -0.1%
FY 2021 $11,618.8M +5.2% $11,351.7M $978.5M +26.5% $8.90 +41.0% $1,930.9M $1,289.4M -1.2%
FY 2022 $11,609.9M -0.1% $11,270.6M $560.4M -42.7% $5.85 -34.3% $1,564.6M $961.1M -25.5%
FY 2023 $12,140.1M +4.6% $11,766.2M $691.5M +23.4% $7.42 +26.8% $2,059.0M $1,491.0M +55.1%
FY 2024 $12,815.5M +5.6% $12,380.3M $936.3M +35.4% $10.73 +44.6% $2,022.0M $1,466.6M -1.6%
FY 2025 $13,643.1M +6.5% $13,103.1M $746.8M -20.2% $9.84 -8.3% $1,886.5M $1,310.6M -10.6%
$

Valuation

Market Price $180.19
Market Cap $11.50B
Enterprise Value N/A
P/E Ratio 18.31
P/B Ratio N/A
FCF Yield 11.39%
Dividend Yield N/A
Shares Outstanding 64,185,000
%

Profitability & Margins

Gross Margin 96.04%
Operating Margin 14.98%
Net Margin 5.47%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) 477.85%
Asset Turnover 87.30x
Revenue 3-Yr CAGR 5.53%
🛡️

Financial Health & Liquidity

Current Ratio 0.05
Cash Ratio 0.22
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $676.44M
Total Debt N/A
Book Value / Share $-10.14
💧

Cash Flow Efficiency

Operating Cash Flow $1.89B
Capital Expenditures (CapEx) $575.86M
Free Cash Flow $1.31B
OCF / Revenue 13.83%
FCF / Revenue 9.61%
FCF 3-Yr CAGR 10.89%
🏷️

Per Share Metrics

EPS (Diluted) $9.84
EPS (Basic) $10.06
Dividends / Share N/A
Book Value / Share $-10.14
EPS YoY Growth -8.29%
🏛️

Balance Sheet (FY 2025)

Total Assets $156.28M
Total Liabilities $3.14B
Stockholders' Equity -$651.08M
Current Assets $156.28M
Current Liabilities $3.14B